Bruker and the University of Warwick Collaborates for Further Development of Extreme Performance Mass Spectrometry
News Jul 22, 2009
Bruker Daltonics has announced the establishment of a long-term collaborative programme for developing both applications and fundamental instrument technology in the area of extreme resolution mass spectrometry.
Building on over 14 years of experience in high performance mass spectrometry at the Department of Chemistry at Warwick, the University’s recent acquisition of both the new Bruker solariX™ 12 Tesla FTMS system and the maXis™ UHR-TOF system again puts the department at the forefront of technology for high performance mass spectrometry.
At the core of the new instruments are improvements, up to an order of magnitude, in previous performance standards. These advances help address the challenging analyses including very complex mixtures in applications such as chemistry, medicinal discovery, protein interactions and petroleomics.
The collaboration is unusual in that it embraces not only topical applications innovation but also fundamental instrument development, the latter headed by Warwick Professor Peter O’Connor, who recently arrived from Boston University, and is one of the world’s most accomplished FTMS instrument development scientists.
“We are very excited to be able to benefit from Peter’s ideas, and have arranged a technical fast-track for his developments to appear in our FTMS products,” commented Dr. Michael Schubert, Executive Vice President for R&D at Bruker Daltonics.
Professor Peter Sadler, Head of Chemistry at the University, whose research interests focus on metals in biology and medicine, the design and mechanism of action of metallodrugs, especially the role of proteins in metal-induced signal transduction said: “In my field state-of-the-art analysis of metal speciation holds the key to major breakthroughs in understanding both how metal ions control natural biological processes, and how metal complexes can be designed as novel therapeutic agents. Moreover, this new Bruker mass spec equipment, and the associated collaboration, will allow our newly established EPSRC Warwick Centre for Analytical Science to compete strongly at the forefront of the field.”
Test For Designer Drugs Could Help Treat Overdose PatientsNews
Medical professionals are scrambling to meet the growing demand for emergency room treatment, but they’re hampered by the lack of a quick and easy test to screen patients for “designer” drugs. Chemists have now developed such a test and are refining it with the hope that hospitals could eventually use it to choose the appropriate treatment.READ MORE
New Chemical Synthesis Process: Synergy of Two Catalysts in One FlaskNews
Researchers report the one-step synthesis of a ketone from an aldehyde by the combination of thiazolium N-heterocyclic carbene and palladium/bisphosphine catalysts in one flask. The two catalysts function in a synergistic manner. This study is expected to lead to new synthesis processes of precursor compounds for medications.READ MORE
Comments | 0 ADD COMMENT
World Congress on Advanced Pharmacy and Clinical Research
Jul 16 - Jul 17, 2018
11th International Conference and Exhibition on Metabolomics & Systems Biology
May 17 - May 19, 2018
10th International Conference on Mass Spectrometry and Chromatography
Oct 08 - Oct 09, 2018